FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer
Conditions: Pancreas Cancer; Adenocarcinoma of the Pancreas Interventions: Drug: Digoxin; Drug: 5Fluorouracil; Drug: Calcium Leucovorin; Drug: Irinotecan; Drug: Oxaliplatin Sponsors: Jean Grem, MD; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials